DSIP Trifluoroacetate for Sleep
Common research-grade salt form of DSIP; same nine-aa sequence with TFA counterion.
Why DSIP Trifluoroacetate for sleep?
Delta Sleep-Inducing Peptide trifluoroacetate is the salt form most peptide vendors ship for research use; the active sequence (W-A-G-G-D-A-S-G-E) is identical to DSIP. Original Schoenenberger work (1977) reported sleep-onset effects after intraventricular dosing in rabbits; subsequent human evidence remains modest, and TFA-salt residues are a known QC concern.
Sleep context: Modulating sleep architecture, slow-wave sleep depth, and circadian regulation. DSIP Trifluoroacetate fits this goal because its category (Sleep) and benefit profile align with the underlying mechanism.
Benefits relevant to sleep
- Reported sleep onset improvement
Reference dosing by bodyweight
Anchored to the most-cited research dose (100 mcg @ 75 kg). Reference only.
| Bodyweight band | Reference dose range |
|---|---|
| <60 kg / <132 lb | 62–84 mcg |
| 60–75 kg / 132–165 lb | 77–103 mcg |
| 75–90 kg / 165–198 lb | 94–126 mcg |
| 90–105 kg / 198–231 lb | 111–150 mcg |
| >105 kg / >231 lb | 128–173 mcg |
Side effects to weigh against sleep benefit
- Headache (rare)
- Vivid dreams
- Limited modern clinical data
Educational use only
This calculator is provided for research and educational purposes. Outputs are derived from the values you enter. Always verify your math and consult a licensed physician before acting on any result.